These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8544842)

  • 1. Synergistic effects of inhibins and müllerian-inhibiting substance on testicular tumorigenesis.
    Matzuk MM; Finegold MJ; Mishina Y; Bradley A; Behringer RR
    Mol Endocrinol; 1995 Oct; 9(10):1337-45. PubMed ID: 8544842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation.
    Mishina Y; Rey R; Finegold MJ; Matzuk MM; Josso N; Cate RL; Behringer RR
    Genes Dev; 1996 Oct; 10(20):2577-87. PubMed ID: 8895659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The müllerian inhibitor and mammalian sexual development.
    Behringer RR
    Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):285-8; discussion 289. PubMed ID: 8570693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Müllerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors.
    Matias-Guiu X; Pons C; Prat J
    Hum Pathol; 1998 Aug; 29(8):840-5. PubMed ID: 9712426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.
    Cipriano SC; Chen L; Kumar TR; Matzuk MM
    Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibin and p27 interact to regulate gonadal tumorigenesis.
    Cipriano SC; Chen L; Burns KH; Koff A; Matzuk MM
    Mol Endocrinol; 2001 Jun; 15(6):985-96. PubMed ID: 11376116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone and follicle-stimulating hormone regulate Müllerian-inhibiting substance messenger ribonucleic acid expression in cultured neonatal rat Sertoli cells.
    Arambepola NK; Bunick D; Cooke PS
    Endocrinology; 1998 Nov; 139(11):4489-95. PubMed ID: 9794457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin alpha knockout mice.
    Burns KH; Agno JE; Sicinski P; Matzuk MM
    Mol Endocrinol; 2003 Oct; 17(10):2053-69. PubMed ID: 12855747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells.
    Lee MM; Seah CC; Masiakos PT; Sottas CM; Preffer FI; Donahoe PK; Maclaughlin DT; Hardy MP
    Endocrinology; 1999 Jun; 140(6):2819-27. PubMed ID: 10342873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directed expression of an oncogene to Sertoli cells in transgenic mice using mullerian inhibiting substance regulatory sequences.
    Peschon JJ; Behringer RR; Cate RL; Harwood KA; Idzerda RL; Brinster RL; Palmiter RD
    Mol Endocrinol; 1992 Sep; 6(9):1403-11. PubMed ID: 1331774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
    Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
    Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substance.
    Behringer RR; Cate RL; Froelick GJ; Palmiter RD; Brinster RL
    Nature; 1990 May; 345(6271):167-70. PubMed ID: 2336108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic engineering to study testicular tumorigenesis.
    Yan W; Burns KH; Matzuk MM
    APMIS; 2003 Jan; 111(1):174-81; discussion 182-3. PubMed ID: 12760377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of androgens in testicular tumor development in inhibin-deficient mice.
    Shou W; Woodruff TK; Matzuk MM
    Endocrinology; 1997 Nov; 138(11):5000-5. PubMed ID: 9348231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexually dimorphic roles of steroid hormone receptor signaling in gonadal tumorigenesis.
    Burns KH; Agno JE; Chen L; Haupt B; Ogbonna SC; Korach KS; Matzuk MM
    Mol Endocrinol; 2003 Oct; 17(10):2039-52. PubMed ID: 12855748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.
    Mikola M; Kero J; Nilson JH; Keri RA; Poutanen M; Huhtaniemi I
    Oncogene; 2003 May; 22(21):3269-78. PubMed ID: 12761497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors.
    Rey R; Sabourin JC; Venara M; Long WQ; Jaubert F; Zeller WP; Duvillard P; Chemes H; Bidart JM
    Hum Pathol; 2000 Oct; 31(10):1202-8. PubMed ID: 11070112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.
    Coerver KA; Woodruff TK; Finegold MJ; Mather J; Bradley A; Matzuk MM
    Mol Endocrinol; 1996 May; 10(5):534-43. PubMed ID: 8732684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadoblastoma: immunohistochemical localization of Müllerian-inhibiting substance, inhibin, WT-1, and p53.
    Hussong J; Crussi FG; Chou PM
    Mod Pathol; 1997 Nov; 10(11):1101-5. PubMed ID: 9388060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in follicular function of 3-month-old calves and mature cows.
    Driancourt MA; Reynaud K; Smitz J
    Reproduction; 2001 Mar; 121(3):463-74. PubMed ID: 11226073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.